Roberts M - Search Results

1

Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.

Cropley I, Douce G, Roberts M, Chatfield S, Pizza M, Marsili I, Rappuoli R, Dougan G. Cropley I, et al. Among authors: roberts m. Vaccine. 1995 Dec;13(17):1643-8. doi: 10.1016/0264-410x(95)00134-m. Vaccine. 1995. PMID: 8719514

2

Recombinant P.69/pertactin: immunogenicity and protection of mice against Bordetella pertussis infection.

Roberts M, Tite JP, Fairweather NF, Dougan G, Charles IG. Roberts M, et al. Vaccine. 1992;10(1):43-8. doi: 10.1016/0264-410x(92)90418-j. Vaccine. 1992. PMID: 1539459

3

A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.

Roberts M, Bacon A, Rappuoli R, Pizza M, Cropley I, Douce G, Dougan G, Marinaro M, McGhee J, Chatfield S. Roberts M, et al. Infect Immun. 1995 Jun;63(6):2100-8. doi: 10.1128/iai.63.6.2100-2108.1995. Infect Immun. 1995. PMID: 7768587 Free PMC article.

4

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

Douce G, Turcotte C, Cropley I, Roberts M, Pizza M, Domenghini M, Rappuoli R, Dougan G. Douce G, et al. Among authors: roberts m. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1644-8. doi: 10.1073/pnas.92.5.1644. Proc Natl Acad Sci U S A. 1995. PMID: 7878032 Free PMC article.

5

Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.

Roberts M, Cropley I, Chatfield S, Dougan G. Roberts M, et al. Vaccine. 1993;11(8):866-72. doi: 10.1016/0264-410x(93)90363-3. Vaccine. 1993. PMID: 8356847

6

Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response.

Anderson R, Dougan G, Roberts M. Anderson R, et al. Among authors: roberts m. Vaccine. 1996 Oct;14(14):1384-90. doi: 10.1016/s0264-410x(96)00036-9. Vaccine. 1996. PMID: 9004450

7

Immunization of mice with DNA encoding fragment C of tetanus toxin.

Anderson R, Gao XM, Papakonstantinopoulou A, Fairweather N, Roberts M, Dougan G. Anderson R, et al. Among authors: roberts m. Vaccine. 1997 Jun;15(8):827-9. doi: 10.1016/s0264-410x(96)00262-9. Vaccine. 1997. PMID: 9234525

8

The use of live attenuated Salmonella for oral vaccination.

Chatfield S, Roberts M, Li J, Starns A, Dougan G. Chatfield S, et al. Among authors: roberts m. Dev Biol Stand. 1994;82:35-42. Dev Biol Stand. 1994. PMID: 7958481 Review.

9

The development of oral vaccines based on live attenuated Salmonella strains.

Chatfield S, Roberts M, Londono P, Cropley I, Douce G, Dougan G. Chatfield S, et al. Among authors: roberts m. FEMS Immunol Med Microbiol. 1993 Jun;7(1):1-7. doi: 10.1111/j.1574-695X.1993.tb00374.x. FEMS Immunol Med Microbiol. 1993. PMID: 8364518 Review.

10

Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin.

Anderson R, Gao XM, Papakonstantinopoulou A, Roberts M, Dougan G. Anderson R, et al. Among authors: roberts m. Infect Immun. 1996 Aug;64(8):3168-73. doi: 10.1128/iai.64.8.3168-3173.1996. Infect Immun. 1996. PMID: 8757849 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,040 results

Search Page

Filters